Jim O’Neill could be in line to take charge of the agency.
BMS illegally promoted schizophrenia drug, says attorney general
Leela Barham considers how the OMA has progressed since its launch.
02/11/2016November 1, 2016
22/11/2016October 20, 2016
08/12/2016October 18, 2016
A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.